Fund Overview of Mirae Asset Nifty 500 Healthcare Etf-growth
-
₹18.83NAV
-
EquityFund Category
Asset Allocation
equities
99.87%other assets or cash equivalents
0.13%Mirae Asset Nifty 500 Healthcare Etf-growth is one Equity mutual fund offered by Mirae Asset Mutual Fund. Launched on 10 Feb 2026, the fund aims Return that are commensurate with the performance of Nifty 500 Healthcare Total Return Index,subject to tracking error over long term.investment in securities constituting in Nifty 500 healthcare total Return Index. The portfolio allocation consists of 99.87% in equities, 0.13% in other assets or cash equivalents.it has delivered a return of 0.00% in the last year, a total return since inception of 2.08%.About Mirae Asset Nifty 500 Healthcare Etf-growth
When exploring investment options individuals often refer to which sip is best based on financial goals.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | -0.17% | -3.70% | 11.10% | 29.16% | 18.03% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | -0.21% | -3.88% | 10.20% | 28.07% | 17.00% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | 2.08% | 2.63% | 13.48% | 26.36% | 16.00% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | 1.98% | 2.28% | 11.98% | 24.68% | 14.39% |
More funds from Mirae Asset Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Mirae Asset Healthcare Fund Regular - Growth
|
₹2,908 | 3.89% | 3.56% | 0.92% | 14.75% | 25.79% |
|
Mirae Asset Healthcare Fund Direct - Growth
|
₹2,908 | 4.00% | 3.93% | 1.65% | 16.41% | 27.64% |
|
Mirae Asset Healthcare Fund Regular-idcw
|
₹2,908 | 3.89% | 3.56% | 0.92% | 14.75% | 25.79% |
|
Mirae Asset Healthcare Fund Direct-idcw
|
₹2,908 | 4.00% | 3.93% | 1.65% | 16.41% | 27.64% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹38.45 | 28.07% | 17.00% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹41.64 | 29.16% | 18.03% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.77 | 26.36% | 16.00% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.40 | 24.68% | 14.39% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹153.25 | 26.75% | - | - |
| ICICI Prudential Nifty Pharma Index Fund Direct - Growth |
₹95 | ₹18.06 | 25.67% | - | - |
| ICICI Prudential Nifty Pharma Index Fund - Growth |
₹95 | ₹17.70 | 24.88% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.37 | 26.92% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.02% | ₹0.73 Cr |
| Divi's Laboratories Ltd | Healthcare | 6.80% | ₹0.50 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.78% | ₹0.49 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.72% | ₹0.49 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.54% | ₹0.48 Cr |
| Cipla Ltd | Healthcare | 6.33% | ₹0.46 Cr |
| Lupin Ltd | Healthcare | 4.66% | ₹0.34 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.10% | ₹0.30 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.78% | ₹0.28 Cr |
| Laurus Labs Ltd | Healthcare | 3.49% | ₹0.25 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.85% | ₹0.21 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.75% | ₹0.20 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.69% | ₹0.20 Cr |
| Biocon Ltd | Healthcare | 2.32% | ₹0.17 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.12% | ₹0.15 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.93% | ₹0.14 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.77% | ₹0.13 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.54% | ₹0.11 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.40% | ₹0.10 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 1.27% | ₹0.09 Cr |
| Gland Pharma Ltd | Healthcare | 1.21% | ₹0.09 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.14% | ₹0.08 Cr |
| Abbott India Ltd | Healthcare | 1.13% | ₹0.08 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.05% | ₹0.08 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 1.04% | ₹0.08 Cr |
| Wockhardt Ltd | Healthcare | 0.94% | ₹0.07 Cr |
| Neuland Laboratories Ltd | Healthcare | 0.92% | ₹0.07 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 0.90% | ₹0.07 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 0.89% | ₹0.06 Cr |
| Piramal Pharma Ltd | Healthcare | 0.81% | ₹0.06 Cr |
| Global Health Ltd | Healthcare | 0.80% | ₹0.06 Cr |
| Natco Pharma Ltd | Healthcare | 0.74% | ₹0.05 Cr |
| Granules India Ltd | Healthcare | 0.70% | ₹0.05 Cr |
| Syngene International Ltd | Healthcare | 0.67% | ₹0.05 Cr |
| Pfizer Ltd | Healthcare | 0.64% | ₹0.05 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 0.62% | ₹0.05 Cr |
| Eris Lifesciences Ltd | Healthcare | 0.61% | ₹0.04 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.58% | ₹0.04 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 0.50% | ₹0.04 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.45% | ₹0.03 Cr |
| Indegene Ltd. | Healthcare | 0.43% | ₹0.03 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.42% | ₹0.03 Cr |
| Metropolis Healthcare Ltd | Healthcare | 0.41% | ₹0.03 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 0.41% | ₹0.03 Cr |
| Poly Medicure Ltd | Healthcare | 0.40% | ₹0.03 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.36% | ₹0.03 Cr |
| Concord Biotech Ltd. | Healthcare | 0.34% | ₹0.02 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.33% | ₹0.02 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 0.29% | ₹0.02 Cr |
| Caplin Point Laboratories Ltd | Healthcare | 0.28% | ₹0.02 Cr |
| Repo | Unspecified | 0.07% | ₹0.01 Cr |
| Net Receivables | Unspecified | 0.06% | ₹0.00 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹41.64 | 29.16% | 18.03% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹38.45 | 28.07% | 17.00% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.77 | 26.36% | 16.00% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.40 | 24.68% | 14.39% | - |
Frequently Asked Questions
Mirae Asset Nifty 500 Healthcare Etf-growth
What is the long-term performance of Mirae Asset Nifty 500 Healthcare Etf-growth?
- Since Inception: 2.08%
What is the portfolio composition of Mirae Asset Nifty 500 Healthcare Etf-growth?
Equity: 99.87%, Others: 0.13%.
What is the market-cap allocation of Mirae Asset Nifty 500 Healthcare Etf-growth?
Large Cap: 47.04%, Mid Cap: 32.58%, Small Cap: 20.39%.
Which are the top companies Mirae Asset Nifty 500 Healthcare Etf-growth has invested in?
- Sun Pharmaceutical Industries Ltd – 10.02% of the fund's portfolio
- Divi's Laboratories Ltd – 6.80% of the fund's portfolio
- Max Healthcare Institute Ltd – 6.78% of the fund's portfolio
- Apollo Hospitals Enterprise Ltd – 6.72% of the fund's portfolio
- Dr. Reddy's Laboratories Ltd – 6.54% of the fund's portfolio
Which are the major sectors Mirae Asset Nifty 500 Healthcare Etf-growth focuses on?
- Healthcare – 99.87% of the fund's portfolio
- Unspecified – 0.13% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





